Vaidya, Vishal S.
Pfizer Inc.,
United States
2025 Rank: 216953
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Urology & Nephrology
Rank in SubField 1: 829 out of 67220 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 216953 | 237099 |
| Total Cites | 471 | 500 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 124 | 125 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 238 | 248 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 391 | 411 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.22 |
| Self-Citation Percentage |
5.80%
|
|
Vaidya, Vishal S.
Pfizer Inc.,
United States
2024 Rank: 204668
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Urology & Nephrology
Rank in SubField 1: 850 out of 65055 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 204668 | 234995 |
| Total Cites | 446 | 460 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 115 | 116 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 212 | 216 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 373 | 383 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.20 |
| Self-Citation Percentage |
3.04%
|
|
Vaidya, Vishal S.
Pfizer Inc.,
United States
2023 Rank: 156616
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Urology & Nephrology
Rank in SubField 1: 636 out of 61487 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 156616 | 169380 |
| Total Cites | 539 | 565 |
| H-index | 12 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 145 | 150 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 285 | 299 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 443 | 460 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
4.60%
|
|
Vaidya, Vishal S.
Pfizer Inc.,
United States
2022 Rank: 121733
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Urology & Nephrology
Rank in SubField 1: 497 out of 55990 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121733 | 137384 |
| Total Cites | 599 | 623 |
| H-index | 13 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 162 | 164 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 319 | 330 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 467 | 480 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.30 |
| Self-Citation Percentage |
3.85%
|
|
Vaidya, Vishal S.
Pfizer Inc.,
United States
2021 Rank: 128178
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Urology & Nephrology
Rank in SubField 1: 527 out of 53247 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 128178 | 148975 |
| Total Cites | 833 | 868 |
| H-index | 16 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 227 | 230 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 451 | 467 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 646 | 668 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.30 |
| Self-Citation Percentage |
4.03%
|
|
Vaidya, Vishal S.
Brigham and Women's Hospital,
United States
2020 Rank: 112497
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Urology & Nephrology
Rank in SubField 1: 486 out of 45124 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112497 | 120813 |
| Total Cites | 675 | 720 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 180 | 186 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 369 | 395 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 518 | 542 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
6.25%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.